-
With artificial intelligence in health care on the rise, eye screenings for diabetic retinopathy are emerging as one of the first proven use cases of AI-based diagnostics in a clinical setting.
-
The FDA granted a request for a qualified health claim from Danone North America. Such claims lack full scientific support but are allowed as long as they include disclaimers.
-
Adults who develop one autoimmune form of diabetes are often misdiagnosed with Type 2. Those wrong diagnoses make it harder to get the appropriate medications and technology to manage blood sugar.
-
Last January, Anderson Ata became the seventh person in the world to receive teplizumab, which researchers say is the first big milestone in treating diabetes since the production of insulin over 100 years ago.
-
Dr. Henry Rodriguez, who is in charge of the USF Center for Diabetes and Endocrinology, said there are classic symptoms to watch out for.
-
New research finds that limiting eating from noon to 8 p.m. helped patients manage weight and blood sugar as much as calorie counting – and was easier to keep up.
-
The medication is called tirzepatide. It is under review to treat obesity in the U.S. A decision is expected later this year.
-
Doctors and patients around the country say getting on the high-demand, injectable drugs requires persistence and a fair amount of luck.
-
Heat is dangerous for the many people with common conditions like diabetes or heart disease. And vulnerable communities face greater exposure to heat and fewer resources to escape it.
-
The law expands subsidized insurance coverage for families of four with incomes up to 300 percent of the federal poverty level, or about $90,000 annually.